Ebihara K, Ogawa Y, Masuzaki H, Shintani M, Miyanaga F, Aizawa-Abe M, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Gavrilova O, Reitman ML,Nakao K: Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 50:1440–1448, 2001
On page 1446 of the above article, the last two reference numbers in Table 2 (27 and 28) should read 28 and “This study,” respectively.
TABLE 2
Leptin, fat mass, and insulin sensitivity in experimental mouse models
Animals . | Treatments . | Leptin . | Fat . | Insulin sensitivity . | Reference number . |
---|---|---|---|---|---|
A-ZIP/F-1 | — | − | − | Decreased | 22 |
Leptin | + | − | Decreased | 25 | |
Leptin | ++ | − | Normalized | This study | |
Fat transplantation | + | + | Normalized | 26 | |
aP2-nSREBP-1c | — | − | ± | Decreased | 23 |
Leptin | + | ± | Normalized | 24 | |
ob/ob | — | − | ++ | Decreased | 28 |
LepTg/+:A-ZIPTg/+ | — | ++ | − | Normalized or increased |
Animals . | Treatments . | Leptin . | Fat . | Insulin sensitivity . | Reference number . |
---|---|---|---|---|---|
A-ZIP/F-1 | — | − | − | Decreased | 22 |
Leptin | + | − | Decreased | 25 | |
Leptin | ++ | − | Normalized | This study | |
Fat transplantation | + | + | Normalized | 26 | |
aP2-nSREBP-1c | — | − | ± | Decreased | 23 |
Leptin | + | ± | Normalized | 24 | |
ob/ob | — | − | ++ | Decreased | 28 |
LepTg/+:A-ZIPTg/+ | — | ++ | − | Normalized or increased |
2001